Exploring the Effects of Opioid-Related Drugs on the Clinical Outcome of Prostate Cancer Patients Via Integrated Bioinformatics Analysis
Molecular Biotechnology · 2026
DOI: 10.1007/s12033-024-01353-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biotechnology, 2026. Verfasst von Yunxuan Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Computational Biology, Analgesics, Opioid. Die Arbeit nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shenzhen Medical Research Fund.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Opioids are the primary regimens for perioperative analgesia with controversial effects on oncological survival. The underlying mechanism remains unexplored. This study developed survival-related gene co-expression networks based on RNA-seq and clinical characteristics from TCGA cohort. Two survival-related networks were identified, and drug-induced transcriptional profiles were predicted. Immune cell infiltration algorithm, least absolute shrinkage and selection operator (LASSO) regression, and cox proportional models were executed to explore the correlation between opioid-related drugs and prostate cancer patient prognosis. The opioid receptor agonists, represented by tramadol, were evidenced for anti-survival effects on prostate cancer by facilitating the DNA replication and cell cycle, and immune cell infiltration. Conversely, opioid receptor antagonists showed pro-survival effects. A novel prognostic model containing CNIH2, MCCC1, and Gleason scores was established and validated in two independent cohorts. This study revealed opioids' effect on prostate cancer progression, and provided a novel model to predict these regulations in clinical outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
- Institute of Urology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. curkey@126.com.
- Institute of Urology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. curkey@126.com.
- Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. xzhang@hust.edu.cn.
- Institute of Urology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. xzhang@hust.edu.cn.
Förderung
- National Natural Science Foundation of China
- Shenzhen Medical Research Fund
Zitieren
APA
Zhang, Y., Liu, Y., Chen, K., Miao, Q., Cao, Q., & Zhang, X. (2026). Exploring the Effects of Opioid-Related Drugs on the Clinical Outcome of Prostate Cancer Patients Via Integrated Bioinformatics Analysis. Molecular Biotechnology. https://doi.org/10.1007/s12033-024-01353-w
Vancouver
Zhang Y, Liu Y, Chen K, Miao Q, Cao Q, Zhang X. Exploring the Effects of Opioid-Related Drugs on the Clinical Outcome of Prostate Cancer Patients Via Integrated Bioinformatics Analysis. Molecular Biotechnology. 2026. doi:10.1007/s12033-024-01353-w
BibTeX
@article{Zhang2026,
author = {Zhang, Yunxuan and Liu, Yuenan and Chen, Kailei and Miao, Qi and Cao, Qi and Zhang, Xiaoping},
title = {Exploring the Effects of Opioid-Related Drugs on the Clinical Outcome of Prostate Cancer Patients Via Integrated Bioinformatics Analysis},
journal = {Molecular Biotechnology},
year = {2026},
doi = {10.1007/s12033-024-01353-w}
}
EUVIMED